Methylsulfonylmethane promotes melanogenesis via activation of JNK in Mel‐Ab cells

Abstract

AbstractObjectiveMethylsulfonylmethane (MSM), which contains organic sulphur, has been used for a long time as a medicinal ingredient because of its benefits to human health. MSM is reported to be protective against certain skin disorders, but it is unknown whether it affects melanin synthesis. Therefore, in our current research, we examined the possibility of MSM controlling the production of melanin in Mel‐Ab melanocytes.MethodsIn Mel‐Ab cells, melanin contents and tyrosinase activities were assessed and quantified. The expression of microphthalmia‐associated transcription factor (MITF) and tyrosinase was evaluated using western blot analysis, while MSM‐induced signalling pathways were investigated.ResultsThe MSM treatment significantly resulted in a dose‐dependent increase in melanin production. Furthermore, MSM elevated melanin‐related proteins, including MITF and tyrosinase. However, the rate‐limiting enzyme of melanin production, tyrosinase, was not directly influenced by it. Therefore, we investigated potential melanogenesis‐related signalling pathways that may have been triggered by MSM. Our findings showed that MSM did not influence the signalling pathways associated with glycogen synthase kinase 3β, cAMP response‐element binding protein, extracellular signal‐regulated kinase, or p38 mitogen‐activated protein kinase. However, MSM phosphorylated c‐Jun N‐terminal kinases/stress‐activated protein kinase (JNK/SAPK), which is known to induce melanogenesis. SP600125, a specific JNK inhibitor, inhibited MSM‐induced melanogenesis.ConclusionTaken together, our study indicates that MSM induces melanin synthesis and may serve as a therapeutic option for hypopigmentary skin disorders such as vitiligo.